Active Ingredient: SUNITINIB
QT prolongation in dogs and monkeys due to calcium channel antagonisation and action potential duration prolongation
https://doi.org/10.1038/bjc.2015.82, https://www.fda.gov/media/178811/download, https://doi.org/10.1161/CIR.0000000000001056, https://doi.org/10.1093/eurheartj/ehab362, https://doi.org/10.1016/S1470-2045(22)00221-2, https://doi.org/10.1007/s40264-013-0047-5